In ER negative breast cancer cells, activating GPER-1 by an agonist such as G1, led to cell cycle arrest and apoptosis suggesting GPER-1 as a promising target for breast cancer therapy (59, 60). The gene discussed is GPER1; the disease is breast cancer.